Gene expression profiling allows us to subcategorize breast cancer into four “intrinsic subtypes”, each with a unique natural history and response to therapy—Luminal A, Luminal B, Basal-like, and HER2 (human epidermal growth factor receptor 2) “enriched” [1,2]. The gene discussed is ERBB2; the disease is breast cancer.